Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in Ontario

Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in Ontario

Background: First-line treatment of epithelial ovarian cancer (EOC) consists of a combination of cytoreductive surgery and platinum-based chemotherapy. Recently, targeted therapies such as bevacizumab have been shown to improve oncologic outcomes in a subset of a high-risk population. The objective...

Full description

Bibliographic Details
Main Authors: Shiru L. Liu, Wing C. Chan, Geneviève Bouchard-Fortier, Stephanie Lheureux, Sarah E. Ferguson, Monika K. Krzyzanowska
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Current Oncology
Subjects:
ovarian cancer
bevacizumab
real-world evidence
health care utilization
Online Access:https://www.mdpi.com/1718-7729/29/8/472

Internet

https://www.mdpi.com/1718-7729/29/8/472

Similar Items